chr2-203726685-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_006139.4(CD28):c.105G>A(p.Ala35=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 1,613,932 control chromosomes in the GnomAD database, including 135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0074 ( 4 hom., cov: 32)
Exomes 𝑓: 0.012 ( 131 hom. )
Consequence
CD28
NM_006139.4 synonymous
NM_006139.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
CD28 (HGNC:1653): (CD28 molecule) The protein encoded by this gene is essential for T-cell proliferation and survival, cytokine production, and T-helper type-2 development. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-203726685-G-A is Benign according to our data. Variant chr2-203726685-G-A is described in ClinVar as [Benign]. Clinvar id is 774413.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CD28 | NM_006139.4 | c.105G>A | p.Ala35= | synonymous_variant | 2/4 | ENST00000324106.9 | |
CD28 | NM_001410981.1 | c.147G>A | p.Ala49= | synonymous_variant | 2/4 | ||
CD28 | NM_001243077.2 | c.105G>A | p.Ala35= | synonymous_variant | 2/4 | ||
CD28 | NM_001243078.2 | c.53-2963G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CD28 | ENST00000324106.9 | c.105G>A | p.Ala35= | synonymous_variant | 2/4 | 1 | NM_006139.4 | P1 | |
CD28 | ENST00000458610.6 | c.147G>A | p.Ala49= | synonymous_variant | 2/4 | 1 | |||
CD28 | ENST00000374481.7 | c.53-2963G>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00740 AC: 1124AN: 151984Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
1124
AN:
151984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00712 AC: 1791AN: 251418Hom.: 19 AF XY: 0.00701 AC XY: 952AN XY: 135886
GnomAD3 exomes
AF:
AC:
1791
AN:
251418
Hom.:
AF XY:
AC XY:
952
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0117 AC: 17136AN: 1461830Hom.: 131 Cov.: 32 AF XY: 0.0112 AC XY: 8175AN XY: 727222
GnomAD4 exome
AF:
AC:
17136
AN:
1461830
Hom.:
Cov.:
32
AF XY:
AC XY:
8175
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00739 AC: 1124AN: 152102Hom.: 4 Cov.: 32 AF XY: 0.00751 AC XY: 558AN XY: 74346
GnomAD4 genome
AF:
AC:
1124
AN:
152102
Hom.:
Cov.:
32
AF XY:
AC XY:
558
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at